Showing 1 - 6 results of 6 for search 'Camille B. Carroll', query time: 0.02s Refine Results
  1. 1
    Digital health technologies and self-efficacy in Parkinson’s: a scoping review

    Digital health technologies and self-efficacy in Parkinson’s: a scoping review by Victoria Allgar, Edward Meinert, Camille B Carroll, Andrew Michael Hall

    Published 2025-01-01
    Get full text
    Article
  2. 2
    Incorporating usability evaluation into iterative development of an online platform to support research participation in Parkinson’s disease: a mixed methods protocol

    Incorporating usability evaluation into iterative development of an online platform to support research participation in Parkinson’s disease: a mixed methods protocol by Stephen Mullin, Edward Meinert, Camille B Carroll, John Whipps, Sue Whipps, Rebecca Chapman, Marie-Louise Zeissler, Kate Hockey, Philip Hockey

    Published 2023-12-01
    Get full text
    Article
  3. 3
    Simvastatin as a neuroprotective treatment for Parkinson’s disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study

    Simvastatin as a neuroprotective treatment for Parkinson’s disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study by Susan Ball, Douglas Webb, Camille B Carroll, Kara Nicola Stevens, Jane Vickery, Vicky Eyre, Richard Wyse, Mike Webber, Andy Foggo, John Zajicek, Alan Whone, Siobhan Creanor

    Published 2019-10-01
    Get full text
    Article
  4. 4
    Ensuring that COVID-19 research is inclusive: guidance from the NIHR INCLUDE project

    Ensuring that COVID-19 research is inclusive: guidance from the NIHR INCLUDE project by Miles D Witham, Alistair S Hall, Camille B Carroll, Eamonn R Maher, Rebecca H Maier, Eleanor Anderson, Paul M Dark, Kim Down, Joanna Knee, Gail A Mountain, Gary Nestor

    Published 2020-11-01
    Get full text
    Article
  5. 5
    Investigating trial design variability in trials of disease-modifying therapies in Parkinson’s disease: a scoping review protocol

    Investigating trial design variability in trials of disease-modifying therapies in Parkinson’s disease: a scoping review protocol by Camille B Carroll, Thea Dominey, Hari Venkatesh Pai, Emma King, Marie-Louise Zeissler, Timothy Boey, Danny Chapman, Gary Rafaloff, Karen G Raphael, Susan Buff, Paul Sharpe, Fintan O’Brien

    Published 2023-12-01
    Get full text
    Article
  6. 6
    Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The ‘Exenatide-PD3’ study

    Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo... by Thomas Foltynie, Rachael Hunter, Lynn Rochester, Dilan Athauda, Patricia Limousin, Alexa King, Simon Skene, Kashfia Chowdhury, Camille B Carroll, Huw Morris, Michele T Hu, Monty Silverdale, Rachel Gibson, Marisa Chau, Christine Lo, Nirosen Vijiaratnam, Christine Girges, Grace Auld, Kate Maclagan, Steve Hibbert, Gordon W Duncan, Ray Chaudhuri, Silvia Del Din, Alison J Yarnall, John Dickson, Vincenzo Libri

    Published 2021-05-01
    Get full text
    Article

Search Tools: